bis
Market Research Report

A quick peek into the report

Europe Flow Cytometry Market

Analysis and Forecast, 2025-2035

 
Some Faq's

Frequently Asked Questions

The global flow cytometry market, valued at $3,392.5 million in 2024, is on a robust growth trajectory and is anticipated to reach $7,371.9 million by 2035.
 

In Europe, flow cytometry devices require CE marking under the EU Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR), depending on use. Manufacturers must demonstrate safety, performance, and clinical evidence through conformity assessment. Classifications vary by application, with clinical-use systems subject to more stringent oversight and notified body review.

This report is essential for flow cytometry instrument and reagent manufacturers, distributors, research organizations, clinical laboratories, academic institutions, investors, and consultants who need an in-depth understanding of current market trends, competitive dynamics, and future opportunities in the global flow cytometry industry.

The following are the USPs of this report:
•    Comprehensive market sizing and detailed segmentation by method, product, application, and region
•    In-depth competitive analysis of key and emerging players
•    Exclusive expert insights on current and future market trends
•    Clear identification of growth opportunities in research and clinical applications
•    Key strategies and developments in the market 

Recent advancements in flow cytometry systems in Europe include spectral cytometry for high-dimensional analysis, imaging flow cytometry combining fluorescence with cellular morphology, and miniaturized microfluidic cytometers for point-of-care use. AI-driven platforms are also enhancing automation in gating, panel design, and data interpretation, streamlining workflows and improving diagnostic precision.